Skip to main content
. 2017 Jul 5;8(34):57278–57301. doi: 10.18632/oncotarget.18985

Table 8. Validation of KNN classification for predicting GS based on epithelial cells only with Biomarkers I.

A Classification
ID B 3+3 3+4 4+3 Total
HPrEpiC 1,820 27 140 79 2,066
% 88.09 1.31 6.78 3.82 100
LNCaP 154 1,535 11,697 4,051 17,437
% 0.88 8.8 67.08 23.23 100
B Classification
ID B 3+3 3+4 4+3 Total
Patient 5 4 49 3,234 8,298 11,585
% 0.03 0.42 27.92 71.63 100
Patient Z 210 679 2,113 6,372 9,374
% 2.24 7.24 22.54 67.98 100
C Classification
Phase B 3+3 3+4 4+3 Total
B1 638 441 865 775 2,719
% 23.46 16.22 31.81 28.5 100
P 420 554 8,239 10,909 20,122
% 2.09 2.75 40.95 54.21 100
D Classification
ID B 3+3 3+4 4+3 Total
Patient 7 8 2,226 2,516 879 5,629
% 0.14 39.55 44.7 15.62 100
Patient 8 239 3,278 4,584 414 8,515
% 2.81 38.5 53.83 4.86 100